CHRS vs NTRS · rev $26.6M vs P/E 18, rev $2.69B
Coherus BioSciences Inc (CHRS) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
CHRS currently screens at market cap $223.7M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the CHRS and NTRS stock pages for the full models.
Not investment advice.